Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms

The aim of this work was to investigate the potential usefulness of Trypanosoma cruzi lysate, recombinant protein JL7, and peptides P013, R13, JL18, JL19, and P0b as serological markers for human Chagas disease. We analyzed 228 sera from Brazilian Chagas disease patients classified into four clinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2012
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00029637_v87_n2_p267_Longhi
http://hdl.handle.net/20.500.12110/paper_00029637_v87_n2_p267_Longhi
Aporte de:
id paper:paper_00029637_v87_n2_p267_Longhi
record_format dspace
spelling paper:paper_00029637_v87_n2_p267_Longhi2023-06-08T14:23:21Z Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms bacterium lysate peptide peptide jl18 peptide jl19 peptide p013 peptide p0beta peptide r13 recombinant antigen recombinant protein recombinant protein jl7 unclassified drug adolescent adult article blood sampling Brazil Chagas disease child controlled study cross reaction disease severity enzyme linked immunosorbent assay female human immunofluorescence major clinical study male school child sensitivity and specificity serology Trypanosoma cruzi visceral leishmaniasis Adolescent Adult Animals Antibodies, Protozoan Antigens, Protozoan Brazil Chagas Disease Child Enzyme-Linked Immunosorbent Assay Female Humans Male Middle Aged Recombinant Proteins Sensitivity and Specificity Trypanosoma cruzi Young Adult The aim of this work was to investigate the potential usefulness of Trypanosoma cruzi lysate, recombinant protein JL7, and peptides P013, R13, JL18, JL19, and P0b as serological markers for human Chagas disease. We analyzed 228 sera from Brazilian Chagas disease patients classified into four clinical groups and 108 from non-chagasic patients. We defined the diagnostic sensitivity, specificity, and Kappa index measured by enzyme-linked immunosorbent assay (ELISA). As previously described, the highest values of diagnostic parameters were achieved for T. cruzi lysate and JL7; peptide P013 showed high specificity but low sensitivity. The other peptides resulted in lower sensitivity and specificity in our ELISA than T. cruzi lysate and JL7 protein. Antibodies against JL7 protein were mainly detected in sera from patients with severe chagasic cardiomyopathy, compared with those from the indeterminate form, whereas peptides failed to discriminate between the clinical forms of the disease. Copyright © 2012 by The American Society of Tropical Medicine and Hygiene. 2012 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00029637_v87_n2_p267_Longhi http://hdl.handle.net/20.500.12110/paper_00029637_v87_n2_p267_Longhi
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic bacterium lysate
peptide
peptide jl18
peptide jl19
peptide p013
peptide p0beta
peptide r13
recombinant antigen
recombinant protein
recombinant protein jl7
unclassified drug
adolescent
adult
article
blood sampling
Brazil
Chagas disease
child
controlled study
cross reaction
disease severity
enzyme linked immunosorbent assay
female
human
immunofluorescence
major clinical study
male
school child
sensitivity and specificity
serology
Trypanosoma cruzi
visceral leishmaniasis
Adolescent
Adult
Animals
Antibodies, Protozoan
Antigens, Protozoan
Brazil
Chagas Disease
Child
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged
Recombinant Proteins
Sensitivity and Specificity
Trypanosoma cruzi
Young Adult
spellingShingle bacterium lysate
peptide
peptide jl18
peptide jl19
peptide p013
peptide p0beta
peptide r13
recombinant antigen
recombinant protein
recombinant protein jl7
unclassified drug
adolescent
adult
article
blood sampling
Brazil
Chagas disease
child
controlled study
cross reaction
disease severity
enzyme linked immunosorbent assay
female
human
immunofluorescence
major clinical study
male
school child
sensitivity and specificity
serology
Trypanosoma cruzi
visceral leishmaniasis
Adolescent
Adult
Animals
Antibodies, Protozoan
Antigens, Protozoan
Brazil
Chagas Disease
Child
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged
Recombinant Proteins
Sensitivity and Specificity
Trypanosoma cruzi
Young Adult
Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
topic_facet bacterium lysate
peptide
peptide jl18
peptide jl19
peptide p013
peptide p0beta
peptide r13
recombinant antigen
recombinant protein
recombinant protein jl7
unclassified drug
adolescent
adult
article
blood sampling
Brazil
Chagas disease
child
controlled study
cross reaction
disease severity
enzyme linked immunosorbent assay
female
human
immunofluorescence
major clinical study
male
school child
sensitivity and specificity
serology
Trypanosoma cruzi
visceral leishmaniasis
Adolescent
Adult
Animals
Antibodies, Protozoan
Antigens, Protozoan
Brazil
Chagas Disease
Child
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged
Recombinant Proteins
Sensitivity and Specificity
Trypanosoma cruzi
Young Adult
description The aim of this work was to investigate the potential usefulness of Trypanosoma cruzi lysate, recombinant protein JL7, and peptides P013, R13, JL18, JL19, and P0b as serological markers for human Chagas disease. We analyzed 228 sera from Brazilian Chagas disease patients classified into four clinical groups and 108 from non-chagasic patients. We defined the diagnostic sensitivity, specificity, and Kappa index measured by enzyme-linked immunosorbent assay (ELISA). As previously described, the highest values of diagnostic parameters were achieved for T. cruzi lysate and JL7; peptide P013 showed high specificity but low sensitivity. The other peptides resulted in lower sensitivity and specificity in our ELISA than T. cruzi lysate and JL7 protein. Antibodies against JL7 protein were mainly detected in sera from patients with severe chagasic cardiomyopathy, compared with those from the indeterminate form, whereas peptides failed to discriminate between the clinical forms of the disease. Copyright © 2012 by The American Society of Tropical Medicine and Hygiene.
title Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
title_short Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
title_full Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
title_fullStr Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
title_full_unstemmed Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
title_sort evaluation of in-house elisa using trypanosoma cruzi lysate and recombinant antigens for diagnosis of chagas disease and discrimination of its clinical forms
publishDate 2012
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00029637_v87_n2_p267_Longhi
http://hdl.handle.net/20.500.12110/paper_00029637_v87_n2_p267_Longhi
_version_ 1768546374681362432